HUTCHMED (LON:HCM) Stock Price Crosses Below Two Hundred Day Moving Average - Time to Sell?

HUTCHMED (China) Limited (LON:HCM - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 239.06 ($3.23) and traded as low as GBX 202.44 ($2.74). HUTCHMED shares last traded at GBX 206 ($2.79), with a volume of 26,863 shares traded.

HUTCHMED Price Performance

The company has a debt-to-equity ratio of 11.97, a current ratio of 2.81 and a quick ratio of 2.97. The firm has a 50-day moving average of GBX 219.79 and a 200-day moving average of GBX 236.90. The stock has a market cap of £2.26 billion, a PE ratio of -53.09 and a beta of 0.76.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).